Can Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Be Used to Treat Persistent Hemothorax After Robotic Lobectomy?
2024

Using tPA and DNase to Treat Hemothorax After Lung Surgery

publication Evidence: low

Author Information

Author(s): Muacevic Alexander, Adler John R, Vivekanandan Deepak Dev, Louis Mena, Canaan Lucas N, Gersch Karen

Primary Institution: Northeast Georgia Medical Center Gainesville

Hypothesis

Can intrapleural tissue plasminogen activator and deoxyribonuclease be used to treat persistent hemothorax after robotic lobectomy?

Conclusion

Intrapleural tPA and DNase can be a safe and effective alternative to surgery for managing retained hemothorax in selected patients.

Supporting Evidence

  • The patient had a retained hemothorax after robotic lobectomy.
  • Initial treatments were insufficient, leading to the use of tPA and DNase.
  • Significant clinical and radiographic improvement was observed after treatment.

Takeaway

Doctors used special medicines to help a patient with a serious problem after lung surgery, and it worked well without needing more surgery.

Methodology

The patient received intrapleural tPA and DNase after traditional treatments failed, leading to significant improvement.

Potential Biases

Potential bias due to the lack of a control group and reliance on a single patient's outcome.

Limitations

The study is based on a single case, limiting generalizability.

Participant Demographics

74-year-old female with a history of COPD and lung cancer.

Digital Object Identifier (DOI)

10.7759/cureus.73999

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication